Novel DUB Inhibitor Platform Addressing Protein Homeostasis

Time: 9:00 am
day: Day Two


  • Mission has developed a world-leading potent and selective DUB inhibitor library
  • Selective tools provide best method for elucidating DUB enzyme regulation of disease pathophysiology
  • USP30 inhibitors exemplify progression from hit to candidate, with more DUB target programs to follow